DUBLIN , April 21, 2022 /PRNewswire/ -- The "Global Myopia and Presbyopia Treatment Market Size, Share & Trends Analysis Report by Myopia Treatment Type (Corrective, Surgical), Presbyopia Treatment Type (Prescription, Contact Lenses), Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global myopia and presbyopia treatment market size is expected to reach USD 28.0 billion by 2028, according to the report. The market is expected to expand at a CAGR of 7.9% from 2021 to 2028.

Growing research and development in the targeted disorders is expected to drive the market considerably over the forecast period. Moreover, the growing prevalence of myopia and high myopia is anticipated to fuel the market during the forecast period. Incidences of myopia in the developing countries of Asia Pacific , such as Japan , China , Singapore , and the Republic of Korea is growing steeply in recent years. According to Statista, myopia cases in the world are expected to rise by 28% in the next decade and by 30% for high myopia. The growing prevalence of myopia and presbyopia is an opportunity for industry players to introduce efficient treatment solutions. Among the developed nations, the U.S. is witnessing a significant boost in the incidence of myopia and presbyopia, especially in individuals over 42 years of age. The introduction of technologically advanced surgical options and high adoption rates in developed countries are expected to boost the market growth in upcoming years. Advanced diagnostic and surgical treatment solutions include LASIK, LASEK, and PRK. Integration of these techniques with artificial intelligence and robot-assisted surgical tools is expected to fuel the number of surgical procedures. The introduction of multifocal intraocular lenses and implantable contact lenses is expected to have a positive impact on the market growth. Myopia And Presbyopia Treatment Market Report Highlights

By myopia treatment type, the single prescription corrective lenses segment is expected to hold a significant revenue share of the market owing to the progression of myopia with age, thus requiring frequent changes of corrective lenses

The progressive multifocals segment is also expected to grow significantly over the forecast period owing to wide acceptance due to aesthetic advantages

The multifocal contact lenses for the correction of presbyopia held the largest revenue share in 2020 largely due to easy availability and effective outcomes

Key Topics Covered: Chapter 1. Methodology and Scope Chapter 2. Executive Summary Chapter 3. Myopia and Presbyopia Treatment Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Industry Value Chain Analysis 3.3.1. Reimbursement framework 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.2. Market restraint analysis 3.4.3. Industry challenges 3.5. Myopia and Presbyopia Treatment Market Analysis Tools 3.5.1. Industry Analysis - Porter's 3.5.1.1. Supplier power 3.5.1.2. Buyer power 3.5.1.3. Substitution threat 3.5.1.4. Threat of new entrant 3.5.1.5. Competitive rivalry 3.5.2. PESTEL Analysis 3.5.2.1. Political landscape 3.5.2.2. Technological landscape 3.5.2.3. Economic landscape 3.5.3. Major Deals & Strategic Alliances Analysis 3.5.4. Market Entry Strategies Chapter 4. Myopia Treatment Type Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Corrective 4.1.1.1. Prescription Lenses 4.1.1.1.1. Single 4.1.1.1.2. Bifocal 4.1.1.1.3. Trifocal 4.1.1.1.4. Others 4.1.1.2. Contact Lenses 4.1.2. Surgical 4.1.3. Drugs 4.2. Myopia Treatment Type Market Share, 2020 and 2028 4.3. Segment Dashboard 4.4. Global Myopia and Presbyopia Treatment Market by Myopia Treatment Type Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2028 for the following 4.5.1. Corrective 4.5.1.1. Prescription Lenses 4.5.1.1.1. Single 4.5.1.1.2. Bifocal 4.5.1.1.3. Trifocal 4.5.1.1.4. Others 4.5.1.2. Contact Lenses 4.5.2. Surgical 4.5.3. Drugs Chapter 5. Presbyopia Treatment Type Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Prescription Lenses 5.1.1.1. Reading Glasses 5.1.1.2. Bifocals 5.1.1.3. Trifocals 5.1.1.4. Progressive Multifocals 5.1.1.5. Office Progressives 5.1.2. Contact Lenses 5.1.2.1. Bifocal 5.1.2.2. Multifocal 5.1.2.3. Monovison 5.1.2.4. Modified Monovision 5.1.3. Intraocular Lenses 5.1.4. Refractive Surgery 5.2. Presbyopia Treatment Type Market Share, 2020 and 2028 5.3. Segment Dashboard 5.4. Global Myopia and Presbyopia Treatment Market by Presbyopia Treatment Type Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2028 for the following 5.5.1. Prescription Lenses 5.5.1.1. Reading Glasses 5.5.1.2. Bifocals 5.5.1.3. Trifocals 5.5.1.4. Progressive Multifocals 5.5.1.5. Office Progressives 5.5.2. Contact Lenses 5.5.2.1. Bifocal 5.5.2.2. Multifocal 5.5.2.3. Monovison 5.5.2.4. Modified Monovision 5.5.3. Intraocular Lenses 5.5.4. Refractive Surgery Chapter 6. Myopia and Presbyopia Treatment: Regional Estimates & Trend Analysis Chapter 7. Competitive Landscape 7.1. Recent Developments & Impact Analysis, By Key Market Participants 7.2. Company/Competition Categorization 7.2.1. Innovators 7.3. Vendor Landscape 7.3.1. List of key distributors and channel partners 7.3.2. Key customers 7.3.3. Key company market share analysis, 2018 7.3.4. Zeimer Ophthalmic Systems AG 7.3.4.1. Company Overview 7.3.4.2. Financial performance 7.3.4.3. Product Benchmarking 7.3.4.4. Strategic Initiatives 7.3.5. NIDEK CO. LTD. 7.3.5.1. Company Overview 7.3.5.2. Financial performance 7.3.5.3. Product Benchmarking 7.3.5.4. Strategic Initiatives 7.3.6. Johnson & Johnson Vision 7.3.6.1. Company Overview 7.3.6.2. Financial performance 7.3.6.3. Product Benchmarking 7.3.6.4. Strategic Initiatives 7.3.7. ZEISS International 7.3.7.1. Company Overview 7.3.7.2. Financial performance 7.3.7.3. Product Benchmarking 7.3.7.4. Strategic Initiatives 7.3.8. ALCON VISION LLC 7.3.8.1. Company Overview 7.3.8.2. Financial performance 7.3.8.3. Product Benchmarking 7.3.8.4. Strategic Initiatives 7.3.9. Bausch & Lomb Incorporated 7.3.9.1. Company Overview 7.3.9.2. Financial performance 7.3.9.3. Product Benchmarking 7.3.9.4. Strategic Initiatives 7.3.10 . Haag-Streit UK 7.3.10.1. Company Overview 7.3.10.2. Financial performance 7.3.10.3. Product Benchmarking 7.3.10.4. Strategic Initiatives 7.3.11 . Topcon Corporation 7.3.11.1. Company Overview 7.3.11.2. Financial performance 7.3.11.3. Product Benchmarking 7.3.11.4. Strategic Initiatives 7.3.12 . Essilor Ltd. 7.3.12.1. Company Overview 7.3.12.2. Financial performance 7.3.12.3. Product Benchmarking 7.3.12.4. Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/nztpuz

Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:https://www.prnewswire.com/news-releases/insights-on-the-myopia-and-presbyopia-treatment-global-market-to-2028---by-myopia-treatment-type-presbyopia-treatment-type-and-region-301529968.html

As we move toward the end of Q2, it’s time to start thinking about earnings. Looking back at the quarter, analysts are predicting earnings growth of 8%, which may rise to 11% heading into next year. It’s a rosy picture, but it’s also not a sure thing. GDP contracted in Q1, by nearly 1.5%, and some estimates are showing 0% growth in Q2. Such results would meet the technical definition of a recession – and recession is hardly the usual environment to find robust earnings growth. Looking at current

Nuclear submarine supplier to be sold to US buyer after diplomatic row Russian default expected within days Retail sales volumes down 0.5pc in May FTSE 100 rises strongly Ambrose Evans-Pritchard: The pro-Brussels establishment is painting Brexit as an economic disaster to reverse it Sign up here for our daily business briefing newsletter

When you need another stream of income for retirement, you might consider an annuity. You purchase the annuity from an insurance company and receive payments back at a later date. Before buying an annuity, it's important to consider how much … Continue reading → The post How Much Does a $300,000 Annuity Pay Per Month? appeared first on SmartAsset Blog.

A Woman's World reacts to Roe v. Wade overturned

At current levels, investors need a 7% to 8% return just to preserve their wealth.

Tesla plant near Shanghai is going to shut down temporarily, according to reports. On Wednesday, Reuters reported that Tesla (ticker: TSLA) will shut down production in China for a couple of weeks at the start of July to upgrade equipment. Tesla didn’t return a request for comment.

These rapidly growing companies are begging to be bought following a peak decline of 34% for the Nasdaq.

“Time is running out for cash-burning companies kept afloat with easy access to capital,” New Constructs CEO David Trainer said in a Thursday research note.

The drop is exciting some Berkshire investors because the stock now trades for 1.3 times Barron's estimate of its June 30 book value, compared with more than 1.5 times at its March high.

SEAL Team is expanding its ranks, adding Raffi Barsoumian (Legends of Tomorrow) as a new series regular for Season 6 of the Paramount+ drama. The actor will play Omar, “a Senior Chief with 15 years of experience as a SEAL,” our sister site Deadline reports. “The son of Syrian immigrants, Omar has a deep understanding […]

With three small children in the house, Kate Middleton and Prince William surely spend plenty of their time parenting....

High-yield dividend stocks are a major component of my stock portfolio. Here are three income stocks that have room for solid gains in the next year and even better gains over the long run. The blue-chip business development company (BDC) Main Street Capital (NYSE: MAIN) has held up better than the S&P 500 index, which is down 21% so far this year.

Bitcoin bear markets aren't unusual. But cryptocurrencies have never faced such an aggressive Federal Reserve. Welcome to the crypto ice age.

Shares in Polestar Automotive Holding UK PLC jumped 16% on their first day of trading Friday, after the Swedish electric-vehicle maker completed a merger with a special-purpose acquisition company amid plans to expand globally. Polestar agreed to be acquired by blank-check company Gores Guggenheim in September. The auto maker is a unit of Volvo Car AB, which in turn is owned by Zhejiang Geely Holding Group Co. of China.

The gallery serves as a place to view and collect the forward-thinking visions of contemporary artists.

The Dow Jones moved higher as yields fell. Tesla stock skidded after CEO Elon Musk voiced a warning. A Warren Buffett stock rose.

Arrived Homes, the single-family real estate investment platform backed by Amazon.com Inc. (NASDAQ: AMZN) founder Jeff Bezos, is ramping up its acquisitions as demand from retail investors grows stronger for fractional real estate. In the past 30 days, the platform has fully funded approximately $11 million worth of rental properties, compared to $5 million for the entire first quarter of 2022. The number of investors using Arrived Homes has doubled in the last two months, making it difficult fo

(Bloomberg) -- Options insurance. Hedging with Treasuries. Using sentiment to pick a bottom. The things that have lessened the pain of past equity selloffs are coming up short this time around.Most Read from BloombergSupreme Court Overturns Roe, Transforming Abortion-Rights FightProtest Latest: NY, DC Marches Grow as Justice’s Home TargetedJustice Kavanaugh Says States May Not Bar Travel to Obtain an AbortionStocks Roar Back With Best Week in a Month: Markets WrapEnding Roe Is Institutional Suic

Meta Pay digital wallet will facilitate hundreds of billions of dollars worth of transactions in virtual reality, tech boss claims

Documentary footage subpoenaed by House Select Committee investigating the Capitol riot